World's Best Scientists 2026 revealed!
Paul D. Brown

Paul D. Brown

D-Index & Metrics

Medicine

D-Index
105
Citations
48169
World Ranking
6705
National Ranking
3540

Overview

Paul D. Brown is affiliated with the Mayo Clinic in the United States and is active in medical research, primarily within the field of Medicine. Their body of work spans several subfields including Pulmonary and Respiratory Medicine, Genetics, Oncology, Radiology, Nuclear Medicine and Imaging, and Surgery.

Their research focuses on topics such as Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Lung Cancer Research Studies, Meningioma and schwannoma management, Management of metastatic bone disease, Cancer-related cognitive impairment studies, and Advanced Radiotherapy Techniques.

Frequent co-authors collaborating with Paul D. Brown include Nadia N. Laack, William G. Breen, Daniel M. Trifiletti, Vinai Gondi, and Minesh P. Mehta.

The main venues publishing Paul D. Brown's work are:

  • Neuro-Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • Neuro-Oncology Advances
  • Radiotherapy and Oncology

Among recent papers authored or co-authored by Paul D. Brown are:

  • Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001, 2020, Journal of Clinical Oncology

Best Publications

  • A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

    Mark R. Gilbert;James J. Dignam;Terri S. Armstrong;Terri S. Armstrong;Jeffrey Scott Wefel

  • Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial

    Paul D. Brown;Kurt Jaeckle;Karla V. Ballman;Elana Farace

  • Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

    Paul W. Sperduto;Norbert Kased;David Roberge;Zhiyuan Xu

  • Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    Paul D. Brown;Paul D. Brown;Karla V. Ballman;Karla V. Ballman;Jane H. Cerhan;S. Keith Anderson

  • Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease

    Brown P;Gibbs Cj;Rodgers-Johnson P;Asher Dm

  • Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

    Paul W. Sperduto;Samuel T. Chao;Penny K. Sneed;Xianghua Luo

  • Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?

    Franck Furno;Kelly S. Morley;Ben Wong;Barry L. Sharp

  • Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

    Mark R. Gilbert;Meihua Wang;Kenneth D. Aldape;Roger Stupp

  • Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

    Jan C. Buckner;Edward G. Shaw;Stephanie L. Pugh;Arnab Chakravarti

  • A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

    Robert B. Jenkins;Hilary Blair;Karla V. Ballman;Caterina Giannini

  • Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

    Paul D. Brown;Stephanie Pugh;Nadia N. Laack;Jeffrey S. Wefel

  • Response assessment criteria for brain metastases: proposal from the RANO group

    Nancy U Lin;Eudocia Q Lee;Hidefumi Aoyama;Igor J Barani

  • Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

    Paul D. Brown;Vinai Gondi;Stephanie Pugh;Wolfgang A. Tome

  • Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial

    Anita Mahajan;Salmaan Ahmed;Mary Frances McAleer;Jeffrey S Weinberg

  • Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)

    Paul W. Sperduto;T. Jonathan Yang;Kathryn Beal;Hubert Pan

  • Whole-brain radiotherapy in the management of brain metastasis.

    Deepak Khuntia;Paul Brown;Jing Li;Minesh P. Mehta

  • Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non-Small Cell Lung Cancer.

    Daniel N. Cagney;Allison M. Martin;Paul J. Catalano;Paul D. Brown

  • Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

    Jann N Sarkaria;Leland S Hu;Ian F Parney;Deanna H Pafundi

  • Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer

    James Welsh;Ritsuko Komaki;Arya Amini;Mark F. Munsell

  • Role and Relevance of Neurocognitive Assessment in Clinical Trials of Patients With CNS Tumors

    Christina A. Meyers;Paul D. Brown

Frequent Co-Authors

Minesh P. Mehta
Minesh P. Mehta University of Maryland, Baltimore
Jan C. Buckner
Jan C. Buckner Mayo Clinic
Mark R. Gilbert
Mark R. Gilbert National Institutes of Health
Bruce E. Pollock
Bruce E. Pollock Mayo Clinic
Karla V. Ballman
Karla V. Ballman Cornell University
Robert L. Foote
Robert L. Foote Mayo Clinic
Pamela K. Allen
Pamela K. Allen The University of Texas MD Anderson Cancer Center
Colin J. Humphreys
Colin J. Humphreys Queen Mary University of London
Evanthia Galanis
Evanthia Galanis Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA offers many pathways beyond the traditional medical doctor route. For students interested in healthcare, there are diverse online degree options that provide flexibility and specialization.

Many aspiring nurses are searching for nursing school that don't require teas, making the entry process less stressful and more accessible. For those aiming to advance from Registered Nurse to a Family Nurse Practitioner, there are streamlined rn to fnp programs available online, helping professionals progress their careers efficiently.

If you’re interested in the administrative side of healthcare, accredited online health administration programs can lead to roles in management, policy, and hospital operations. Additionally, for those passionate about wellness and prevention, an online bachelor's in nutrition creates opportunities in public health, education, and private practice.

Exploring these alternatives can provide a more tailored, accessible, and flexible entry into the medical and health sciences fields.

Best Scientists Citing Paul D. Brown

Trending Scientists

Recently Published Articles